News for Vaxcyte, Inc. (PCVX)

The downside comes after PCVX reports mixed results from a mid-stage study on its pneumococcal vaccine in infants.

Vaxcyte, Inc.'s stock fell 50% despite positive vaccine results. See how FDA uncertainty, competition, and Phase 3 delays impact it. Click for my PCVX update.

Vaxcyte, Inc.'s positive phase 2 results for VAX-24 show promise in preventing invasive pneumococcal disease in infants. Click for PCVX's market opportunity.

U.S. stocks traded mixed midway through trading, with the Dow Jones gaining more than 100 points on Monday. The Dow traded up 0.30% to 41,710.68 while the NASD...

U.S. stocks traded lower this morning, with the Nasdaq Composite falling more than 300 points on Monday. Following the market opening Monday, the Dow traded do...

ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero

We recently compiled a list of the 10 Best Debt Free Mid Cap Stocks to Buy Now. In this article, we are going to take a look at where Vaxcyte, Inc. (NASDAQ:PCVX) stands against the other debt free mid cap stocks. Debt-free mid-cap stocks currently offer compelling investment opportunities, especially in today’s high-interest-rate environment. With […]

**media[580791]**

We recently published a list of the 10 Best Mid Cap Biotech Stocks to Buy. In this article, we are going to take a look at where Vaxcyte, Inc. (NASDAQ:PCVX) stands against the other best mid cap biotech stocks to buy. Is the Biotech Sector Oversaturated? On March 6, Jared Holz, Mizuho health care equity […]

We recently published a list of the 10 Best Mid Cap Biotech Stocks to Buy. In this article, we are going to take a look at where Vaxcyte, Inc.

Transaction Overview On March 6, 2025, RA Capital Management, L.P. made a significant addition to its portfolio by acquiring 1,605,725 shares of Janux Therapeut

”“ Gino Santini Appointed as Chairman of the Board, Michael Heffernan, Founder and Chairman and Gwen A. Melincoff, Board Member to Retire from Board ”“

**media[568249]**

We recently compiled a list of the 10 Cash-Rich Mid Cap Stocks To Buy Now. In this article, we are going to take a look at where Vaxcyte, Inc.

Exploring the robust pipeline and innovative vaccine technology of Vaxcyte Inc (PCVX).Assessing the financial trajectory and market potential of Vaxcyte Inc's

We recently published a list of the 10 Best Vaccine Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Vaxcyte, Inc.

Vaxcyte, Inc. (NASDAQ:PCVX) Q4 2024 Earnings Conference Call February 25, 2025 4:30 PM ETCompany ParticipantsAndrew Guggenhime - President and CFOGrant...

The following slide deck was published by Vaxcyte, Inc.

Cash Equivalents and Investments: $3.13 billion as of December 31, 2024.Net Proceeds from Equity Offerings: $2.2 billion in 2024.R&D Expenses: Increased due to